$RGC @RegencellBio announced the results from an analysis of a total of 51 individuals enrolled in its additional Evaluation and Assessment of RGC-COV19TM TCM through a Holistic approach efficacy trial (the "EARTH-B Trial") conducted by Regencell Bioscience Asia Limited ("Regencell Asia") of its novel COVID-19 oral TCM candidate RGC-COV19TM (Regencell Bioscience (RGCA-CV01) liquid formulation). https://finance.yahoo.com/news/regencell-bioscience-announces-additional-earth-120500852.html
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.